BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31184706)

  • 1. Cystic and Encapsulated Atypical Thymoma (World Health Organization Type B3).
    Lindholm KE; Moran CA
    Am J Clin Pathol; 2019 Sep; 152(4):512-516. PubMed ID: 31184706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic epithelial neoplasms with sebaceous differentiation: a clinicopathological and immunohistochemical study of 8 cases.
    Kalhor N; Moran CA
    Hum Pathol; 2019 Apr; 86():124-128. PubMed ID: 30537491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilocular thymic cyst associated with thymoma: a clinicopathologic study of 20 cases with an emphasis on the pathogenesis of cyst formation.
    Nakamura S; Tateyama H; Taniguchi T; Ishikawa Y; Kawaguchi K; Fukui T; Mizuno T; Ishiguro F; Yokoi K
    Am J Surg Pathol; 2012 Dec; 36(12):1857-64. PubMed ID: 23026930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymoma with pseudosarcomatous stroma: report of an unusual histologic variant of thymic epithelial neoplasm that may simulate carcinosarcoma.
    Suster S; Moran CA; Chan JK
    Am J Surg Pathol; 1997 Nov; 21(11):1316-23. PubMed ID: 9351569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xanthomatous Thymoma: A Clinicopathologic and Immunohistochemical Study of 10 Cases.
    Lindholm KE; Moran CA
    Am J Clin Pathol; 2019 May; 151(6):593-597. PubMed ID: 30816919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymoma and thymic carcinoma associated with multilocular thymic cyst: a clinicopathologic analysis of 18 cases.
    Shen X; Jin Y; Shen L; Sun Y; Chen H; Li Y
    Diagn Pathol; 2018 Jun; 13(1):41. PubMed ID: 29945642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymomas With a Prominent Alveolar Growth Pattern: A Clinicopathologic and Immunohistochemical Study of 12 Cases.
    Kalhor N; Moran CA
    Am J Clin Pathol; 2019 Jan; 151(2):171-175. PubMed ID: 30247496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corpuscular thymoma: entity or variant of organotypical thymomas WHO B2/B3?
    Laeng RH; Eimoto T; Kuo TT; Zettl A; Marx A; Moschopulos M; Tateyama H; Shimokawa K
    Pathol Res Pract; 2006; 202(10):697-704. PubMed ID: 16887284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmoplastic spindle cell thymomas: a clinicopathologic and immunohistochemical study of 14 cases.
    Weissferdt A; Moran CA
    Hum Pathol; 2013 Apr; 44(4):623-7. PubMed ID: 23084585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.
    Kuo TT; Chan JK
    Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas.
    Roden AC; Yi ES; Jenkins SM; Donovan JL; Cassivi SD; Garces YI; Marks RS; Aubry MC
    Hum Pathol; 2015 Jan; 46(1):17-25. PubMed ID: 25455993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymomas with prominent glandular differentiation: a clinicopathologic and immunohistochemical study of 12 cases.
    Weissferdt A; Moran CA
    Hum Pathol; 2013 Aug; 44(8):1612-6. PubMed ID: 23528863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micronodular Thymomas With Prominent Cystic Changes: A Clinicopathological and Immunohistochemical Study of 25 Cases.
    Oramas DM; Moran CA
    Int J Surg Pathol; 2021 Jun; 29(4):352-357. PubMed ID: 33026263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical thymoma (epithelial-rich thymoma, well-differentiated thymic carcinoma, WHO type B3 thymoma): A conundrum.
    Weissferdt A; Moran CA
    Pathol Res Pract; 2023 May; 245():154459. PubMed ID: 37043966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of immunohistochemical markers and thymic cortical microenvironmental cells in distinguishing thymic carcinoma from type b3 thymoma or lung squamous cell carcinoma.
    Hayashi A; Fumon T; Miki Y; Sato H; Yoshino T; Takahashi K
    J Clin Exp Hematop; 2013; 53(1):9-19. PubMed ID: 23801129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p63 in thymomas and normal thymus.
    Dotto J; Pelosi G; Rosai J
    Am J Clin Pathol; 2007 Mar; 127(3):415-20. PubMed ID: 17276940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymic epithelial neoplasms with rhabdomyomatous component: a clinicopathological and immunohistochemical study of 7 cases.
    Kalhor N; Moran CA
    Hum Pathol; 2019 Jan; 83():100-105. PubMed ID: 30217623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of p63 and XIAP in thymic hyperplasia and thymomas.
    Wu M; Sun K; Gil J; Gan L; Burstein DE
    Am J Clin Pathol; 2009 May; 131(5):689-93. PubMed ID: 19369629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.
    Hishima T; Fukayama M; Hayashi Y; Fujii T; Arai K; Shiozawa Y; Funata N; Koike M
    Hum Pathol; 1998 Apr; 29(4):330-8. PubMed ID: 9563781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary thymic adenocarcinomas: a clinicopathological and immunohistochemical study of 16 cases with emphasis on the morphological spectrum of differentiation.
    Kalhor N; Moran CA
    Hum Pathol; 2018 Apr; 74():73-82. PubMed ID: 29339175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.